Javascript must be enabled to continue!
A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
View through CrossRef
<b><i>Introduction:</i></b> LUM-201 (ibutamoren, formerly MK-0677) is an orally administered GH secretagogue receptor agonist under development for treatment of pediatric growth hormone deficiency (PGHD). <b><i>Methods:</i></b> The GH response to a single dose of LUM-201 and to other GH secretagogues used for diagnosis of PGHD were compared in 68 pediatric subjects participating in a trial for growth hormone deficiency. <b><i>Results:</i></b> LUM-201 elicited greater GH responses than observed in GHD diagnostic tests with arginine, glucagon, clonidine, L-dopa, and insulin-induced hypoglycemia [median and interquartile ranges 15.0 ng/mL (3.5, 49) vs. 5.5 ng/mL (1.8, 7.6) (<i>p</i> < 0.0001)]. The difference between responses was greatest in subjects with higher baseline IGF-I concentrations and higher GH responses to standard GH stimuli. <b><i>Conclusion:</i></b> LUM-201 elicits greater GH responses than standard stimuli in subjects with higher peak GH in response to conventional testing and is potentially an orally administered treatment alternative to injectable rhGH in a subset of patients with adequate responses to an acute dose of LUM-201.
Title: A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
Description:
<b><i>Introduction:</i></b> LUM-201 (ibutamoren, formerly MK-0677) is an orally administered GH secretagogue receptor agonist under development for treatment of pediatric growth hormone deficiency (PGHD).
<b><i>Methods:</i></b> The GH response to a single dose of LUM-201 and to other GH secretagogues used for diagnosis of PGHD were compared in 68 pediatric subjects participating in a trial for growth hormone deficiency.
<b><i>Results:</i></b> LUM-201 elicited greater GH responses than observed in GHD diagnostic tests with arginine, glucagon, clonidine, L-dopa, and insulin-induced hypoglycemia [median and interquartile ranges 15.
0 ng/mL (3.
5, 49) vs.
5.
5 ng/mL (1.
8, 7.
6) (<i>p</i> < 0.
0001)].
The difference between responses was greatest in subjects with higher baseline IGF-I concentrations and higher GH responses to standard GH stimuli.
<b><i>Conclusion:</i></b> LUM-201 elicits greater GH responses than standard stimuli in subjects with higher peak GH in response to conventional testing and is potentially an orally administered treatment alternative to injectable rhGH in a subset of patients with adequate responses to an acute dose of LUM-201.
Related Results
The Knowledge Transfer Process of Mor Lam Ruang Toh Klon Khon Kaen Style to Prisoners at Khon Kaen Central Prison
The Knowledge Transfer Process of Mor Lam Ruang Toh Klon Khon Kaen Style to Prisoners at Khon Kaen Central Prison
The objective of this research was to convey the art of performing Mor Lam Rueang Tor Klon Khon Kaen style, by transferring the singing and performing techniques to prisoners in Kh...
The Geographic Distribution of Pediatric Anesthesiologists Relative to the US Pediatric Population
The Geographic Distribution of Pediatric Anesthesiologists Relative to the US Pediatric Population
BACKGROUND:
The geographic relationship between pediatric anesthesiologists and the pediatric population has potentially important clinical and policy implications. In ...
The Pediatric Anesthesiology Workforce: Projecting Supply and Trends 2015–2035
The Pediatric Anesthesiology Workforce: Projecting Supply and Trends 2015–2035
BACKGROUND:
A workforce analysis was conducted to predict whether the projected future supply of pediatric anesthesiologists is balanced with the requirements of the in...
De Novo Anemia and Relationship with Vitamin C Deficiency and Zinc Deficiency in a Southern Delaware Population, a Retrospective Analysis
De Novo Anemia and Relationship with Vitamin C Deficiency and Zinc Deficiency in a Southern Delaware Population, a Retrospective Analysis
Abstract
Background:
Vitamin C is an essential dietary nutrient. It is a water soluble vitamin that exists in the body primarily in the reduced form A...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract
Chemotherapy-induced peripheral neuropathy is a dose-limiting debilitating symptom that can affect many patients treated with anticancer treatments. The res...
Clinical Implications of Cytopenias in the U.S. Immunodeficiency Network Registry
Clinical Implications of Cytopenias in the U.S. Immunodeficiency Network Registry
Rationale
The correlation between cytopenias and infection, malignancy, and mortality has not been systematically characterized in patients with inborn errors of ...
Abstract 2094: Conjugates of TLR9 and STING agonists achieved profound synergistic effects in vitro and in vivo
Abstract 2094: Conjugates of TLR9 and STING agonists achieved profound synergistic effects in vitro and in vivo
Abstract
Introduction: Both Toll-like receptor 9 (TLR9) and STING pathways are two important pathways involved in immune activation. We reasoned that concurrent acti...

